Surgery News and Research

RSS

CeloNova BioSciences' Embozene Microspheres receives approval

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

14 Oct 2009

Renal artery stenosis does not necessitate surgical procedures

Some invasive procedures that are becoming increasingly common as a first line of treatment for patients diagnosed with narrowed arteries in and around the kidneys may not be necessary, according to a new study by researchers at Wake Forest University Baptist Medical Center.

14 Oct 2009

Survey shows etiology of current mastectomy rates is multifactorial

With there being a concern that mastectomy is excessively used as a treatment for breast cancer, a survey of nearly 2,000 women indicates that breast-conserving surgery was attempted as the initial therapy for about 75 percent of those surveyed, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

ATS CryoMaze Probe receives CE Mark

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the receipt of CE Mark for the ATS CryoMaze® 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.

14 Oct 2009

New diagnostic technology to detect breast cancer

"We were ready to start a family when a mammogram revealed an abnormal mass in my left breast," said Staci Sansolo, 34, of New Jersey. A biopsy revealed the mass was not cancer, but a second-round test found another area of concern.

14 Oct 2009

Endovascular procedure for abdominal aortic aneurysm may reduce mortality rate

Patients who received the less-invasive endovascular repair of an abdominal aortic aneurysm had a lower risk of death in the first 30 days after the procedure compared to patients who an open repair, but both procedures had similar rates of death after two years, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

Use of minimally invasive procedures for radical prostatectomy has advantages as well as complications

New research indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy, which have increased significantly in recent years, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

OPKO Health signs agreement with Schering-Plough to acquire assets relating to NK-1 program

OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering’s neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.

14 Oct 2009

Increase in adiponectin hormone levels protects against sepsis-related mortality

A hormone naturally found in the fat that surrounds the abdominal organs for the first time has been linked to death related to sepsis, surgeons reported at the 2009 Clinical Congress of the American College of Surgeons. A study exhibited at the conference showed that low levels of the hormone adiponectin placed animals at a profoundly high risk of death from a septic insult.

14 Oct 2009

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

After helping thousands of patients get their lives back through minimally invasive endoscopic spine surgery at facilities in Tampa, Scottsdale, and soon in Philadelphia, the Laser Spine Institute (LSI) announces the opening of their newest medical consultation facilities -- in Beverly Hills, Ca., and Fort Lauderdale, Fla., in October -- which aim to meet the growing demand for LSI's spinal procedures and provide greater convenience for local patients.

14 Oct 2009

Bicycle-related injuries on the rise

Record-high gasoline prices, the slowdown in the economy, and increasing environmental sensitivity are leading more people to bike to work or for play. But an adequate infrastructure may not be in place to protect cyclists from serious injury according to surgeons who presented a new study on the issue during a scientific paper session at the 2009 Clinical Congress of the American College of Surgeons.

14 Oct 2009

Patients at highly rated hospitals have a 52% lower chance of dying: Study

The largest annual study of patient outcomes at each of the nation’s 5,000 nonfederal hospitals found a wide gap in quality between the nation’s best hospitals and all others. According to the study, issued today by HealthGrades, the leading independent healthcare ratings organization, patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average, a quality chasm that has persisted for the last decade even as mortality rates, in general, have declined.

14 Oct 2009

Bladder cancer patients benefit from anticancer drug that is used to treat lung and colon malignancies: Study

An anticancer drug that is commonly used to treat lung and colon malignancies is having a benefit and potentially prolonging survival in patients with invasive bladder cancer, researchers reported at the 2009 Clinical Congress of the American College of Surgeons.

14 Oct 2009

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft (“Augment”), to autograft for use in hindfoot and ankle fusion surgery.

14 Oct 2009

Endoscopic surgery reduces postoperative discomfort and recovery time

Endoscopic surgery has steadily gained in popularity since it was developed in the 1980s. Dr. Richard Siegfried has teamed with Dr. Louis Quartararo one of only a handful of surgeons who have been trained to perform endoscopic surgery on the spine.

14 Oct 2009

ASAPS and SAGE to publish Aesthetic Surgery Journal in 2010

Los Angeles, London, New Delhi, Singapore and Washington DC (October 13, 2009) The American Society for Aesthetic Plastic Surgery (ASAPS) has partnered with SAGE to publish the Aesthetic Surgery Journal (ASJ) beginning in 2010.

14 Oct 2009

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.

14 Oct 2009

Clinical trial results of the LensAR Laser System to be presented at the 2009 AAO and PAAO joint meeting

LensAR, Inc., a leading developer of next generation laser technology for cataract surgery and other ocular applications, today announced that data from a recently completed clinical trial of the LensAR Laser System will be presented at the upcoming 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and Pan-American Academy of Ophthalmology (PAAO). The meeting will be held October 23 - 27, 2009 in San Francisco, CA.

13 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic findings in the fields of obesity and osteoporosis at medical meetings later this month.

13 Oct 2009

Surgery News and Research

CeloNova BioSciences' Embozene Microspheres receives approval

Renal artery stenosis does not necessitate surgical procedures

Survey shows etiology of current mastectomy rates is multifactorial

ATS CryoMaze Probe receives CE Mark

New diagnostic technology to detect breast cancer

Endovascular procedure for abdominal aortic aneurysm may reduce mortality rate

Use of minimally invasive procedures for radical prostatectomy has advantages as well as complications

OPKO Health signs agreement with Schering-Plough to acquire assets relating to NK-1 program

Increase in adiponectin hormone levels protects against sepsis-related mortality

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

Bicycle-related injuries on the rise

Patients at highly rated hospitals have a 52% lower chance of dying: Study

Bladder cancer patients benefit from anticancer drug that is used to treat lung and colon malignancies: Study

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

Endoscopic surgery reduces postoperative discomfort and recovery time

ASAPS and SAGE to publish Aesthetic Surgery Journal in 2010

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

Clinical trial results of the LensAR Laser System to be presented at the 2009 AAO and PAAO joint meeting

Johnson & Johnson announces financial results for the third quarter of 2009

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News